from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv2062c/cobN

LFCtreatmentdescriptionclass of inhibitor

-1.355

Amikacinug/mL Amikacintranslation

-1.365

Cap5-10ug/mL Capreomycintranslation

-2.092

Rox10-50 ug/mL Roxithromycintranslation

0.223

SM2-5 ug/mL Streptomycintranslation

-3.209

Tet5-10 ug/mL Tetracyclinetranslation

-1.284

Rif0.2-5ug/mL Rifampicintranscription

-0.261

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.288

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-2.126

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.208

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.114

Clofazimine10-13 ug/mL Clofaziminerespiration

0.623

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-1.642

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-1.670

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.265

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.698

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.132

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.925

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.309

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.196

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-1.054

KCN5-20 ug/mL Potassium cyaniderespiration

1.580

NaN30.2-2 mM Sodium aziderespiration

0.100

Nigericin50 uM Nigericinrespiration

-0.743

TRC10-150 ug/mL Triclosanrespiration

-1.475

TRZ10-25 ug/mL Thioridazinerespiration

-0.586

Valinomycin0.5-10 uM Valinomycinrespiration

1.750

ZnSO42 mM ZnSO4respiration

0.361

menadione6-10 ug/mL Menadionerespiration

0.222

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.545

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.041

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

1.114

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.995

NRP_1Non-replicating persistence stage 1dosRassociated

0.572

Amp0.2mg/mL AmpicillincellWall

0.534

Cephalexin20-100 ug/mL CephalexincellWall

0.276

Cerulenin0.32-5 ug/mL CerulenincellWall

0.084

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.120

EMB10-20 ug/mL EthambutolcellWall

0.326

Eta12-40 ug/mL EthionamidecellWall

0.247

INH0.2-0.4 ug/mL IsoniazidcellWall

0.464

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.745

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.880

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.292

BZA0.12 mg/mL BenzamidearomaticAmides

0.553

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.512

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.341

H2O24 mM hydrogen peroxideDNAdamaging

0.776

Levo10 ug/mL LevofloxacinDNAdamaging

0.308

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.190

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.595

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.156

UVUV-irradiationDNAdamaging

-0.525

ARP41-4 ug/mL Antitubercular compound ARP4?

0.935

Antimycin12.5-50 ug/mL Antimycin A?

0.487

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.991

PA_110-50 ug/mL Antitubercular compound PA-1?

0.794

PA_2110-50 ug/mL Antitubercular compound PA-21?

0.073

PA8240.2-2 ug/mL PA-824?

-1.237

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.125

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.357

Verapamil50 uM Verapamil?

0.406

mercaptoethanol2 mM 2-Mercaptoethanol?

0.757

methoxatin10-20 ug/mL Methoxatin?